Budge James 4

What Happened

• Hinge Health CFO Budge James sold a total of 11,006 shares in three open‑market transactions on March 23, 2026, for aggregate proceeds of roughly $465,138. The individual trades were: 1,988 shares at $41.29 ($82,076), 8,346 shares at $42.45 ($354,299), and 672 shares at $42.80 ($28,763). These were disposals (sales), not purchases.

Key Details

• Transaction date: 2026-03-23; Form 4 filed 2026-03-24 (appears timely).
• Individual trades and reported prices/values:
  • 1,988 shares @ $41.29 = $82,076 (weighted avg range reported: $40.73–$41.69).
  • 8,346 shares @ $42.45 = $354,299 (weighted avg range reported: $41.78–$42.77).
  • 672 shares @ $42.80 = $28,763 (weighted avg range reported: $42.78–$42.87).
• Total shares sold: 11,006; total proceeds: about $465,138.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnotes: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted June 12, 2025 (pre‑planned sales). Footnotes also provide weighted‑average price ranges and offer to provide breakdowns by price upon request.

Context

• These were planned sales under a Rule 10b5‑1 plan, which allows insiders to pre‑specify trades and is commonly used to avoid trading on nonpublic information. Such sales are often routine and do not, by themselves, indicate the insider’s current view of company prospects.